Jianglin Colin Liang (Jianglin Liang)

Years Active: 2019-2021
Publications (10 Years): 3

Vertex Pharmaceuticals Inc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vertex Pharmaceuticals Inc Sep 17 2007

United States

Sr Research Scientist :: Chemical Technology

Publications

Jon H Come, Timothy J Senter, Michael P Clark, John J Court, Zachary Gale-Day, Wenxin Gu, Elaine Krueger, Jianglin Colin Liang, Mark Morris, Suganthini Nanthakumar, Hardwin O'Dowd, Francois Maltais, Ganesh Iyer, John Andreassi, Christina Boucher, Tony Considine, Cameron S Moody, William Taylor, Arun K Mohanty, Yulin Huang, Harmon Zuccola, Joyce Coll, Kenneth C Bonanno, Kevin J Gagnon, Lu Gan, Fan Lu, Hong Gao, Ananthisrinivas Chakilam, Juntyma Engtrakul, Bin Song, Dan Crawford, Elisabeth Doyle, Tal Kramer, Bryan Vought, Jonathan Phillips, Raymond Kemper, Martin Sanders, Rebecca Swett, Brinley Furey, Ray Winquist, Mark E Bunnage, Katrina L Jackson, Paul S Charifson, Sanjay S Magavi
Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1. Journal of medicinal chemistry (2021)
Qing Tang, Alex M Aronov, David D Deininger, Simon Giroux, David J Lauffer, Pan Li, Jianglin Colin Liang, Kira McGinty, Steven Ronkin, Rebecca Swett, Nathan Waal, Diane Boucher, Pamella J Ford, Cameron S Moody
Discovery of Potent, Selective Triazolothiadiazole-Containing c-Met Inhibitors. ACS medicinal chemistry letters 12 (6) (2021)
Joseph S Capani, John E Cochran, Jianglin Colin Liang
CsF-Mediated in Situ Desilylation of TMS-Alkynes for Sonogashira Reaction. The Journal of organic chemistry 84 (14) (2019)

Jianglin Colin Liang.css-eqlu8i{font-size:small;padding-left:4px;} (Jianglin Liang)